Jean‐Marie Boher

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

Gwénaëlle Gravis, Jean‐Marie Boher, Florence Joly et al. · European Urology · 2015 · 454 citations

Urology, Genitourinary Cancer, Getug-afu15 Trial +7

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

Rémy Nicolle, Yuna Blum, Laëtitia Marisa et al. · Cell Reports · 2017 · 194 citations · Full text

Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens

Jean‐Robert Delpéro, Philippe Bachellier, Nicolas Régenet et al. · HPB · 2013 · 166 citations · Full text

Evaluable Specimens, Surgical Oncology, Resection Margins +6

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

Gwénaëlle Gravis, Jean‐Marie Boher, Karim Fizazi et al. · European Urology · 2014 · 128 citations · Full text

Prognostic Factors, Urology, Genitourinary Cancer +6

Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients

Jean-Louis Pujol, Jean‐Marie Boher, Jean Grenier et al. · Lung Cancer · 2001 · 128 citations

Cyfra 21-1, Medicine, Pathology +8